Research ArticleArticle
ADAMTS5 Is a Biomarker for Prediction of Response to Infliximab in Patients with Rheumatoid Arthritis
KENSEI TSUZAKA, YUKA ITAMI, TSUTOMU TAKEUCHI, NAOSHI SHINOZAKI and TETSUO MORISHITA
The Journal of Rheumatology July 2010, 37 (7) 1454-1460; DOI: https://doi.org/10.3899/jrheum.091285
KENSEI TSUZAKA
YUKA ITAMI
TSUTOMU TAKEUCHI
NAOSHI SHINOZAKI
REFERENCES
- 1.↵
- Maini R,
- St. Clair EW,
- Breedveld F,
- Furst D,
- Kalden J,
- Weisman M,
- et al.
- 2.↵
- Lipsky PE,
- van der Heijde DM,
- St. Clair EW,
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al.
- 3.↵
- Klareskog L,
- van der Heijde D,
- de Jager JP,
- Gough A,
- Kalden J,
- Malaise M,
- et al.
- 4.↵
- Breedveld FC,
- Weisman MH,
- Kavanaugh AF,
- Cohen SB,
- Pavelka K,
- van Vollenhoven R,
- et al.
- 5.↵
- 6.↵
- Keystone EC,
- Kavanaugh AF,
- Sharp JT,
- Tannenbaum H,
- Hua Y,
- Teoh LS,
- et al.
- 7.↵
- Lequerré T,
- Jouen F,
- Brazier M,
- Clayssens S,
- Klemmer N,
- Ménard JF,
- et al.
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- Yamanishi Y,
- Boyle DL,
- Clark M,
- Maki RA,
- Tortorella MD,
- Arner EC,
- et al.
- 15.↵
- 16.↵
- 17.↵
- Prevoo ML,
- van ‘t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 18.↵
- 19.↵
- 20.↵
- Tsuzaka K,
- Nozaki K,
- Kumazawa C,
- Shiraishi K,
- Setoyama Y,
- Yoshimoto K,
- et al.
- 21.↵
- Furst DE,
- Breedveld FC,
- Kalden JR,
- Smolen JS,
- Burmester GR,
- Bijlsma JW,
- et al.
- 22.↵
- 23.↵
- 24.↵
- Trocmé C,
- Marotte H,
- Baillet A,
- Pallot-Prades B,
- Garin J,
- Grange L,
- et al.
- 25.↵
- Bondeson J,
- Lauder S,
- Wainwright S,
- Amos N,
- Evans A,
- Hughes C,
- et al.
In this issue
The Journal of Rheumatology
Vol. 37, Issue 7
1 Jul 2010
ADAMTS5 Is a Biomarker for Prediction of Response to Infliximab in Patients with Rheumatoid Arthritis
KENSEI TSUZAKA, YUKA ITAMI, TSUTOMU TAKEUCHI, NAOSHI SHINOZAKI, TETSUO MORISHITA
The Journal of Rheumatology Jul 2010, 37 (7) 1454-1460; DOI: 10.3899/jrheum.091285